McMillan Office’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$656K Sell
41,297
-73
-0.2% -$1.13K 0.08% 110
2026
Q1
$559K Sell
41,370
-1,043
-2% -$14.6K 0.07% 108
2025
Q4
$528K Buy
+42,413
New +$458K 0.06% 118

Other funds holding VTRS

McMillan Office's VTRS Position: Q2 2026 in Review

McMillan Office reduced its Viatris (VTRS) stake by 0.18% in Q2 2026, selling an estimated $1.13K and leaving 41,297 shares worth $656K. The position accounts for 0.08% of the portfolio, ranked #110.

McMillan Office first reported a position in VTRS in Q4 2025 and has held it in 3 quarters since. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • McMillan Office held 41,297 shares of Viatris worth $656K as of Q2 2026.
  • McMillan Office sold 73 Viatris shares in Q2 2026, an estimated $1.13K.
  • Viatris made up 0.08% of McMillan Office's portfolio in Q2 2026, its #110 holding.
  • McMillan Office first reported a position in Viatris in Q4 2025 and has held it in 3 quarters since.
  • 1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on McMillan Office's 13F filing for Q2 2026, filed 13 Aug 2026.